Table 4

Summary of values of the coefficients of standard deviation function and Kα coefficients

GeneChip/average/SD/CV
No. of probe sets
Cons. samp. size
No. of arrays
No. of comp.
Coefficient. of st. dev. function
Average Kalpha values in given probability intervals











a1
a2
0.500
0.600
0.700
0.800
0.900
0.950
0.990
0.995

Total average [sum]


[682]
[900]
9.66
0.266
0.642
0.808
1.009
1.275
1.711
2.145
3.226
3.741
Total SD




9.99
0.146
0.033
0.039
0.043
0.045
0.052
0.080
0.270
0.390
Total CV




1.03
0.550
0.052
0.049
0.043
0.035
0.030
0.037
0.084
0.104

HuGeneFL [a1]
7070
12
11
54
8.61
0.115
0.64
0.81
1.01
1.27
1.71
2.16
3.41
4.09
HuGeneFL [b]
7070
12
13
78
8.09
0.418
0.61
0.77
0.97
1.24
1.73
2.24
3.58
4.18
HuGeneFL [c]
7070
25
5
10
34.58
0.435
0.61
0.76
0.94
1.20
1.60
2.03
3.39
4.10
HuGeneFL [c]
7070
25
5
10
28.93
0.393
0.59
0.73
0.92
1.18
1.60
2.07
3.42
4.07

HuGeneFL avg [sum]


[34]
[152]
20.05
0.34
0.61
0.77
0.96
1.22
1.66
2.13
3.45
4.11
HuGeneFL SD




13.71
0.15
0.02
0.03
0.04
0.04
0.07
0.10
0.09
0.05
HuGeneFL CV




0.68
0.44
0.04
0.04
0.04
0.04
0.04
0.05
0.03
0.01

HG-U95Av2 [d]
12559
12
5
10
6.30
0.688
0.61
0.78
1.00
1.30
1.83
2.32
2.98
3.26
HG-U95Av2 [e1]
12559
25
15
15
10.49
0.199
0.65
0.82
1.01
1.27
1.68
2.07
3.05
3.55
HG-U95Av2 [e2]
12559
25
15
15
10.59
0.200
0.64
0.81
1.01
1.26
1.67
2.07
3.07
3.56
HG-U95Av2 [e3]
12559
25
15
15
10.41
0.189
0.63
0.80
1.00
1.25
1.66
2.07
3.06
3.55
HG-U95Av2 [e4]
12559
25
12
12
10.91
0.185
0.63
0.79
0.99
1.24
1.66
2.04
3.02
3.50
HG-U95Av2 [e5]
12559
25
4
2
6.50
0.394
0.65
0.82
1.01
1.26
1.65
2.05
3.05
3.62
HG-U95Av2 [f]
12559
25
4
2
5.64
0.155
0.64
0.81
1.00
1.25
1.66
2.04
2.92
3.31
HG-U95Av2 [g1]
12559
25
2
1
4.79
0.479
0.61
0.76
0.95
1.20
1.64
2.10
3.22
3.71
HG-U95Av2 [g1]
12559
25
5
10
3.31
0.500
0.64
0.80
1.00
1.26
1.69
2.09
2.98
3.29

HG-U95Av2 avg [sum]


[77]
[82]
7.66
0.33
0.63
0.80
1.00
1.26
1.68
2.09
3.04
3.48
HG-U95Av2 SD




2.94
0.19
0.02
0.02
0.02
0.03
0.06
0.09
0.08
0.16
HG-U95Av2 CV




0.38
0.57
0.02
0.02
0.02
0.02
0.04
0.04
0.03
0.05

HG-U95B [d]
12563
12
5
10
16.26
0.636
0.63
0.80
1.01
1.30
1.80
2.28
3.18
3.68
HG-U95B [e5]
12563
25
2
1
17.95
0.167
0.64
0.80
0.99
1.24
1.65
2.02
3.08
3.54
HG-U95C [d]
12587
12
5
10
20.57
0.603
0.64
0.81
1.02
1.30
1.77
2.25
3.39
3.98
HG-U95C [e5]
12587
25
2
1
16.42
0.178
0.63
0.79
0.99
1.23
1.62
2.00
3.06
3.61
HG-U95D [d]
12587
12
5
10
39.79
0.501
0.62
0.78
0.99
1.28
1.77
2.33
3.80
4.42
HG-U95D [e5]
12587
25
2
1
54.45
0.240
0.63
0.79
0.99
1.23
1.62
2.05
2.98
3.48
HG-U95E [d]
12582
12
5
10
31.84
0.534
0.60
0.76
0.97
1.27
1.78
2.29
3.53
4.08
HG-U95E [e5]
12582
25
2
1
45.64
0.215
0.63
0.79
1.00
1.25
1.64
2.02
2.88
3.31

HG-U95B to E avg [sum]


[28]
[44]
30.37
0.38
0.63
0.79
0.99
1.26
1.71
2.16
3.24
3.76
HG-U95B to E SD




14.87
0.20
0.01
0.01
0.02
0.03
0.08
0.14
0.31
0.37
HG-U95B to E CV




0.49
0.53
0.02
0.02
0.02
0.02
0.05
0.07
0.10
0.10

HG-U133A 2.0 [e6]
22225
25
15
15
4.55
0.091
0.65
0.82
1.02
1.28
1.72
2.14
3.14
3.62
HG-U133A 2.0 [e7]
22225
25
15
15
4.50
0.106
0.66
0.84
1.04
1.31
1.75
2.17
3.18
3.63
HG-U133A 2.0 [e8]
22225
25
12
12
4.10
0.108
0.67
0.84
1.05
1.32
1.77
2.21
3.26
3.75
HG-U133A 2.0 [h1]
22225
25
8
4
3.91
0.288
0.64
0.80
1.00
1.26
1.67
2.08
3.05
3.54
HG-U133A 2.0 [i1]
22225
12
4
6
6.25
0.210
0.65
0.82
1.01
1.27
1.68
2.08
3.04
3.48
HG-U133A 2.0 [j]
22225
25
5
10
6.54
0.390
0.62
0.79
0.98
1.25
1.68
2.10
3.13
3.62
HG-U133A 2.0 [j]
22225
25
5
10
5.54
0.393
0.62
0.79
0.98
1.25
1.66
2.08
3.10
3.64
HG-U133A 2.0 [k1]
22225
25
6
15
3.68
0.672
0.63
0.80
1.00
1.27
1.71
2.11
2.84
3.16
HG-U133A 2.0 [k1]
22225
25
3
3
4.95
0.435
0.59
0.74
0.93
1.19
1.65
2.15
3.37
3.79
HG-U133A 2.0 [l1]
22225
25
6
3
6.45
0.151
0.64
0.81
1.01
1.27
1.68
2.08
3.06
3.55
HG-U133A 2.0 [l2]
22225
25
12
6
6.78
0.148
0.65
0.82
1.02
1.27
1.67
2.06
2.93
3.33

HG-U133A 2.0 avg [sum]


[91]
[99]
5.21
0.27
0.64
0.80
1.00
1.27
1.69
2.11
3.10
3.56
HG-U133A 2.0 SD




1.15
0.18
0.02
0.03
0.03
0.03
0.04
0.05
0.15
0.18
HG-U133A 2.0 CV




0.22
0.67
0.03
0.03
0.03
0.03
0.02
0.02
0.05
0.05

HG-U133 Plus 2 [i2]
54000
50
8
10
3.94
0.188
0.68
0.85
1.06
1.33
1.76
2.17
3.11
3.55
HG-U133 Plus 2 [l3]
54000
50
20
27
4.03
0.086
0.65
0.82
1.02
1.28
1.69
2.07
2.95
3.34

HG-U133 Plus 2 avg [sum]


[28]
[37]
3.99
0.14
0.67
0.83
1.04
1.30
1.72
2.12
3.03
3.44

HG-Focus [k2]
8756
12
9
36
4.13
0.216
0.70
0.87
1.08
1.35
1.76
2.15
3.06
3.47
HG-Focus [k2]
8756
12
4
6
4.13
0.181
0.68
0.86
1.07
1.33
1.76
2.18
3.08
3.56
HG-Focus [k2]
8756
12
4
6
3.90
0.198
0.70
0.87
1.08
1.36
1.81
2.22
3.15
3.55
HG-Focus [k2]
8756
12
4
6
3.69
0.176
0.68
0.86
1.07
1.35
1.79
2.19
3.17
3.64
HG-Focus [k2]
8756
12
5
10
3.46
0.183
0.67
0.85
1.05
1.33
1.77
2.19
3.12
3.49
HG-Focus [k2]
8756
12
4
6
4.01
0.205
0.71
0.89
1.10
1.38
1.81
2.19
3.11
3.53
HG-Focus [k2]
8756
12
4
6
3.98
0.174
0.68
0.85
1.06
1.32
1.74
2.14
3.06
3.43

HG-Focus avg [sum]


[34]
[76]
3.90
0.19
0.69
0.86
1.07
1.35
1.78
2.18
3.11
3.52
HG-Focus SD




0.24
0.02
0.01
0.02
0.02
0.02
0.03
0.03
0.04
0.07
HG-Focus CV




0.06
0.08
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.02

MG-Mu11kSubA, SubB [a]
13069
12
10
20
9.98
0.121
0.59
0.75
0.95
1.22
1.70
2.20
3.65
4.48
MG-Mu11kSubA, SubB [a]
13069
12
10
20
8.03
0.170
0.59
0.74
0.94
1.20
1.68
2.19
3.78
4.66
MG-Mu11kSubA, SubB [a]
13069
12
10
20
8.21
0.145
0.60
0.76
0.96
1.23
1.70
2.21
3.70
4.52
MG-Mu11kSubA, SubB [a]
13069
12
10
20
5.32
0.139
0.56
0.71
0.91
1.19
1.71
2.30
4.03
4.84
MG-Mu11kSubA, SubB [m1]
13069
12
8
4
13.86
0.321
0.64
0.81
1.01
1.28
1.73
2.22
3.62
4.24
MG Mu11kSubA, SubB [n1]
13069
12
20
10
11.84
0.420
0.66
0.82
1.01
1.26
1.71
2.21
3.61
4.32

MG-Mu11kSubA, SubB avg [sum]


[68]
[94]
9.54
0.219
0.61
0.77
0.96
1.23
1.70
2.22
3.73
4.51
MG-Mu11kSubA, SubB SD




3.03
0.122
0.04
0.04
0.04
0.04
0.02
0.04
0.16
0.22
MG-Mu11kSubA, SubB CV




0.32
0.557
0.06
0.05
0.04
0.03
0.01
0.02
0.04
0.05

Mu19kSubA, B, C [m2]
12420
12
12
6
15.41
0.314
0.63
0.79
0.99
1.25
1.73
2.26
3.95
4.56

MG-U74Av2 [o]
12588
12
6
6
8.72
0.180
0.59
0.75
0.95
1.23
1.70
2.20
3.56
4.30
MG-U74Av2 [o]
12588
12
5
4
6.97
0.230
0.58
0.74
0.94
1.23
1.71
2.24
3.68
4.48
MG-U74Av2 [p]
12588
12
7
21
9.50
0.125
0.59
0.75
0.95
1.24
1.72
2.21
3.54
4.30
MG-U74Av2 [q]
12588
12
5
4
4.97
0.229
0.68
0.85
1.06
1.33
1.76
2.19
3.23
3.76
MG-U74Av2 [l4]
12588
12
9
9
7.50
0.111
0.67
0.83
1.03
1.30
1.73
2.13
3.09
3.53
MG-U74Av2 [r]
12588
12
10
20
4.69
0.269
0.65
0.82
1.02
1.29
1.73
2.17
3.31
3.89
MG-U74Av2 [r]
12588
12
3
3
3.30
0.238
0.64
0.80
1.00
1.27
1.71
2.17
3.48
4.04
MG-U74Av2 [e5]
12588
12
2
1
3.83
0.184
0.64
0.81
1.00
1.27
1.69
2.10
3.15
3.80
MG-U74Av2 [g2]
12588
12
2
1
13.50
0.451
0.64
0.81
1.01
1.27
1.72
2.16
3.36
3.95
MG U74Av2 [n2]
12400
12
26
13
6.56
0.113
0.64
0.80
1.00
1.27
1.70
2.12
3.15
3.67

MG-U74Av2 avg [sum]


[75]
[82]
6.96
0.213
0.63
0.80
1.00
1.27
1.72
2.17
3.36
3.97
MG-U74Av2 SD




3.07
0.101
0.03
0.04
0.04
0.03
0.02
0.04
0.20
0.31
MG-U74Av2 CV




0.44
0.472
0.06
0.05
0.04
0.02
0.01
0.02
0.06
0.08

MG-U430A [l5]
22636
25
10
5
7.68
0.132
0.65
0.81
1.01
1.27
1.68
2.06
2.94
3.36
MG-U430A [l6]
22636
25
5
10
10.08
0.265
0.67
0.84
1.04
1.30
1.71
2.10
2.98
3.35
MG-U430A [l6]
22636
25
5
10
9.44
0.160
0.65
0.81
1.01
1.27
1.67
2.05
2.93
3.30

MG-U430A


[20]
[25]
9.07
0.186
0.65
0.82
1.02
1.28
1.69
2.07
2.95
3.34
MG-U430A




1.24
0.070
0.01
0.02
0.02
0.02
0.02
0.03
0.03
0.03
MG-U430A




0.14
0.377
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01

RG-U34A [h2]
8740
12
35
34
1.82
0.316
0.64
0.81
1.01
1.28
1.73
2.21
3.40
3.95
RG-U34A [l7]
8740
12
6
3
3.25
0.226
0.68
0.85
1.06
1.33
1.76
2.17
3.20
3.77
RG-U34A, [l8]
8740
12
4
2
6.01
0.146
0.65
0.83
1.03
1.29
1.72
2.11
3.10
3.60

RG-U34A avg [sum]


[45]
[39]
3.70
0.229
0.66
0.83
1.03
1.30
1.74
2.16
3.24
3.78
RG-U34A SD




2.13
0.085
0.02
0.02
0.02
0.02
0.02
0.05
0.15
0.17
RG-U34A CV




0.58
0.371
0.03
0.03
0.02
0.02
0.01
0.02
0.05
0.05

RT-U34 Neurobiology [l7]
982
12
40
20
1.77
0.194
0.60
0.75
0.96
1.22
1.65
2.08
3.12
3.38

Drosophila [s]
13976
12
6
6
2.20
0.081
0.66
0.83
1.04
1.31
1.73
2.17
3.21
3.67

E. coli [t]
7290
12
38
39
3.09
0.337
0.65
0.83
1.04
1.32
1.78
2.24
3.45
4.03
E. coli [u]
7290
12
15
30
1.88
0.302
0.65
0.83
1.04
1.34
1.81
2.29
3.47
4.04

E. Coli avg [sum]


[53]
[69]
2.23
0.228
0.64
0.81
1.02
1.30
1.74
2.19
3.31
3.78

ATH1 [v1]
22700
25
14
17
9.22
0.307
0.68
0.85
1.05
1.31
1.71
2.09
2.95
3.31
ATH1 [v1]
22700
25
34
36
11.18
0.269
0.68
0.85
1.05
1.31
1.71
2.08
2.91
3.26
ATH1 [w]
22700
25
8
4
6.26
0.279
0.65
0.81
1.01
1.27
1.69
2.10
3.06
3.45
ATH1 [x]
22700
25
4
2
3.09
0.232
0.68
0.85
1.05
1.31
1.72
2.12
3.17
3.70
ATH1 [y]
22700
25
4
2
3.07
0.247
0.66
0.82
1.02
1.28
1.68
2.08
3.09
3.60

ATH1 avg [sum]


[64]
[61]
6.57
0.267
0.67
0.84
1.04
1.30
1.70
2.09
3.03
3.46
ATH1 SD




3.63
0.029
0.01
0.02
0.02
0.02
0.02
0.02
0.11
0.19
ATH1 CV




0.55
0.108
0.02
0.02
0.02
0.02
0.01
0.01
0.03
0.05

Arabidopsis [v2]
8200
12
7
8
7.69
0.403
0.75
0.94
1.14
1.40
1.79
2.15
2.89
3.18

No. of probe sets is approximate number of the probe sets on array, Cons. samp. size is number of the probe pairs in a consecutive sample, No. of arrays is a number of arrays tested, No. of comp. is the number of pair-wise comparisons among the replicates, coefficients a1 and a2 are the coefficients of standard deviation function and Kalpha is the coefficient determining probability interval; "h." stands for "human," "m." for "murine." Average values, sum of arrays and comparisons (in square brackets), standard deviations (SD) and coefficients of variation (CV) of each GeneChip type are printed in bold italics.

Data sources:

a1 – J. P. Novak et al., HuGeneFl, IMR90 human cell line [10].

a2 – J. P. Novak et al., HuGeneFl, mouse tissues, adult male C57BL/6 [10].

b – A.-M. Mes-Masson, P. Tonin and coworkers, HuGeneFL, normal ovarian surface epithelial (NOSE) primary cell cultures, private communication.

c – P. Permana, HuGeneFL, human skeletal muscle tissue [35].

d – P. Tonin and A.-M. Mes-Masson and coworkers, HG-U95A to E, epithelial ovarian cancer (EOC) cell line [36].

e1 – Affymetrix, HG-U95A, latin square, experiments 1 to 5.

e2 – Affymetrix, HG-U95A, latin square, experiments 6 to 10.

e3 – Affymetrix, HG-U95A, latin square experiments 11 to 15.

e4 – Affymetrix, HG-U95A, latin square, experiments 16 to 19.

e5 – Affymetrix, HG-U95A to E, Demo Data.

e6 – Affymetrix, HG-U133A, latin square, experiments 1 to 5.

e7 – Affymetrix, HG-U133A, latin square, experiments 6 to 10.

e8 – Affymetrix, HG-U133A, latin square, experiments 11 to 14.

f – M. S. Rolph, HG-U95Av2, primary human bronchial epithelial cells.

g1 – Z. Gatalica, HG-U95Av2, breast tumor tissues and normal breast tissue samples [37].

g2 – Z. Gatalica, MG-U74Av2, mouse kidney tissue.

h1 – M. Boerma, HG-U133A 2.0, primary human umbilical vein endothelial cells (HUVECs) and the immortalized HUVEC cell line EA.hy926 [38].

h2 – M. Boerma, RG-U34A, cultures enriched for neonatal rat cardiac myocytes or fibroblasts [39].

i1 – M. Hajduch, HG-U133A 2.0.

i2 – M. Hajduch, HG-U133 plus 2.

j – S. Y. Kim and D. J. Volsky, HG-U133A 2.0, human fetal astrocytes, normal and pseudotyped HIV-1 infected [40].

k1 – O. Modlich, HG-U133A 2.0, human superficial and invasive bladder tumors [41].

k2 – O. Modlich and Raschke, Focus arrays, human lymphoma cell line Kaspas-422, DSMZ no.: ACC 32 (follicular B cell).

l1 – C. Wang and J. Xu, HG-U133A 2.0, human lymphoblast cell line.

l2 – C. Wang and J. Xu, HG-U133A 2.0, human pancreatic islet.

l3 – C. Wang and J. Xu, HG-U133 Plus 2, Stratagene Universal Human Reference RNA, Ambion Human Brain Reference RNA and mixtures of both in different concentrations.

l4 – C. Wang and J. Xu, MG-U74Av2, mouse biliary epithelial cells.

l5 – C. Wang and J. Xu, MG-U430A, mouse spleen.

l6 – C. Wang and J. Xu, MG-U430A, myofibroblast cell line.

l7 – C. Wang and J. Xu, RG-U34A, rat livers.

l8 – C. Wang and J. Xu, RG-U34A, rat bone marrow stem cells.

m1 – McInnes and coworkers, MG-Mu11kSubA, SubB, retinal RNA samples from WT and Rom1 knock-out mice [36].

m2 – McInnes, Szego and coworkers, MG-Mu19kSubA, SubB, SubC, retinal RNA samples from WT and Rom1 knock-out mice [42].

n1 – Burton, McGehee and coworkers, MG-Mu11kSubA, SubB, 3T3-L1 adipocytes [43].

n2 – Burton, McGehee and coworkers, MG-U74Av2,3T3-L1 adipocyte cultures [44].

o – M. Cosio, MG-U74Av2, lung tissues, murine strains NZW and AKR.

p – R. St-Arnaud, MG-U74Av2, C2C12 cells [45].

q – J. Hidalgo, MG-U74Av2, cortex samples, C57B6 normal and IL6 KO mice [46].

r – D. Radzioch, C. Guilbault and coworkers, MG-U74Av2, C57BL/6 (B6) WT and C57BL/6-Cftr-/- (KO) inbred mice [15].

s – S. E. Choe, Drosophila, Drosophila Gene Collection release 1.0 cDNA clones [19].

t – F. Blattner, E. coli antisense genome, E. coli K-12 strain MG1655 and an isogenic fnr::Spr Smr strain [47].

u – J. Slonczewski and S. BonDurant, E. coli antisense genome, E. coli K-12 strain W3110 [48].

v1 – E. Blumwald and J. Sottosanto, ATH1, A. thaliana ecotype Wassilewskija, wild-type line (WS), nhx1 'knockout' line, and a knockout restoration line; [49] and unpublished data.

v2 – E. Blumwald and J. Sottosanto, arabidopsis, A. thaliana ecotype Wassilewskija, wild-type line (WS), and a nhx1 'knockout' line (unpublished data).

w – D. Honys and D. Twell, ATH1, Arabidopsis thaliana ecotype Landsberg erecta plants [50].

x – E. Nambara and K. Nakabayashi, ATH1, Arabidopsis thaliana (L.) Heynh of ecotype Columbia [51].

y – E. Nambara and K. Tatematsu, ATH1, Arabidopsis thaliana (L.) Heynh of ecotype Columbia [52].

Novak et al. Biology Direct 2006 1:27   doi:10.1186/1745-6150-1-27